Literature DB >> 36138115

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation.

You-Jung Choi1,2, Bongseong Kim3, Tae-Min Rhee2,4, Hyun-Jung Lee2,4, Heesun Lee2,5, Jun-Bean Park2,4, Seung-Pyo Lee2,4, Kyung-Do Han6, Yong-Jin Kim2,4, Hyung-Kwan Kim7,8,9.   

Abstract

Although atrial fibrillation (AF) is a well-established risk factor for ischemic stroke (IS) in hypertrophic cardiomyopathy (HCM), the risk of IS in HCM patients without documented AF is less recognized. This nationwide population-based cohort study using Korean National Health Insurance database included 8,328 HCM patients without documented AF and 1:2 propensity score-matched 16,656 non-HCM controls between 2010 and 2016. The primary outcome was an incident IS. During a mean follow-up of 6.1 years, IS occurred in 328/8,328 (3.9%) patients with HCM and 443/16,656 (2.7%) controls. The overall incidence of IS was 0.72/100 person-years in the HCM group, which was significantly higher than that in the control group (0.44/100 person-years) (HR 1.64; 95% CI 1.424-1.895; P < 0.001). The overall incidence of IS was 1.36/100 person-years in HCM patients aged ≥ 65 and 2.32/100 person-years years in those with heart failure, respectively. In the HCM group, age ≥ 65 years (adjusted HR 2.74; 95% CI 2.156-3.486; P < 0.001) and chronic heart failure (adjusted HR 1.75; 95% CI 1.101-2.745; P = 0.018) were independent risk factors for IS. HCM patients without documented AF are at a greater risk of IS, especially in those 65 years of age or older or those with chronic heart failure.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36138115     DOI: 10.1038/s41598-022-19895-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  29 in total

Review 1.  Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.

Authors:  Oliver P Guttmann; M Shafiqur Rahman; Constantinos O'Mahony; Aris Anastasakis; Perry M Elliott
Journal:  Heart       Date:  2013-09-07       Impact factor: 5.994

2.  Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Authors:  Ethan J Rowin; Anais Hausvater; Mark S Link; Patrick Abt; William Gionfriddo; Wendy Wang; Hassan Rastegar; N A Mark Estes; Martin S Maron; Barry J Maron
Journal:  Circulation       Date:  2017-09-15       Impact factor: 29.690

Review 3.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

Authors:  Hyun-Jung Lee; Hyung-Kwan Kim; Jin-Hyung Jung; Kyung-Do Han; Heesun Lee; Jun-Bean Park; Hyue Mee Kim; Yong-Jin Kim; Steve R Ommen
Journal:  Stroke       Date:  2019-07-25       Impact factor: 7.914

5.  Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.

Authors:  You-Jung Choi; Eue-Keun Choi; Kyung-Do Han; Jin-Hyung Jung; Jiesuck Park; Euijae Lee; Wonseok Choe; So-Ryoung Lee; Myung-Jin Cha; Woo-Hyun Lim; Seil Oh
Journal:  Int J Cardiol       Date:  2018-08-11       Impact factor: 4.164

Review 6.  Inherited cardiomyopathies.

Authors:  Hugh Watkins; Houman Ashrafian; Charles Redwood
Journal:  N Engl J Med       Date:  2011-04-28       Impact factor: 91.245

7.  Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.

Authors:  Shintaro Haruki; Yuichiro Minami; Nobuhisa Hagiwara
Journal:  Stroke       Date:  2016-03-03       Impact factor: 7.914

8.  Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.

Authors:  Laurent Fauchier; Arnaud Bisson; Alexandre Bodin; Julien Herbert; Pascal Spiesser; Bertrand Pierre; Nicolas Clementy; Anne Bernard; Dominique Babuty; Gregory Y H Lip
Journal:  Stroke       Date:  2021-10-04       Impact factor: 7.914

Review 9.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Steve R Ommen; Seema Mital; Michael A Burke; Sharlene M Day; Anita Deswal; Perry Elliott; Lauren L Evanovich; Judy Hung; José A Joglar; Paul Kantor; Carey Kimmelstiel; Michelle Kittleson; Mark S Link; Martin S Maron; Matthew W Martinez; Christina Y Miyake; Hartzell V Schaff; Christopher Semsarian; Paul Sorajja
Journal:  Circulation       Date:  2020-11-20       Impact factor: 29.690

10.  Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.

Authors:  Ting-Tse Lin; Yen-Ling Sung; Tsung-Yu Ko; Chih-Kuo Lee; Lian-Yu Lin; Jimmy Ji-Ming Juang; Cho-Kai Wu
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.